Did you know that new weight loss medications, such as GLP-1 and GLP-1 & GIP therapies, can make losing weight easier by reducing appetite, regulating blood sugar levels, and increasing your energy levels
White C, Ji S, Cai H, et al (2012) Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders
DSIP may influence neurotransmitters and the HPA stress axis, potentially affecting cortisol levels, growth hormone release, and stress resilience
The REDEFINE 1 and REDEFINE 2 Phase 3 trials used a once-weekly subcutaneous dose of cagrilintide 2.4 mg combined with semaglutide 2.4 mg, reached after roughly 16 weeks of dose titration
In some clinical observations on striae gravidarum during pregnancy, pregnant women use cream containing Dihexa peptide, and regularly massage the abdominal skin in the late pregnancy or postpartum period